Dear Friends and Family,
As many of you know, my Dad, Jeff Monsein, was diagnosed with Multiple Myeloma in March of 2012. Multiple myeloma is the second most common form of blood cancer and, sadly, has one of the lowest five-year relative survival rates of all cancers. While there is no cure, great progress is being made.
Five years ago I did not think my Dad would be here today. Doctors at preliminary appointments told us our time would be limited. However, after seeing myeloma specialists, it was found that my father's cancer is smoldering. A person can have smoldering myeloma for several years before progressing to stage 1 multiple myeloma. As we have come to understand this complex diagnosis and disease, our family has been able to travel, celebrate weddings and births, and cherish the time we have together.
Jeff is a successful small business owner, husband to Janice, father to four children, Rachel (31), Sarah (29), Rebecca (27), and Ryan (23), and grandfather to three, Carter (6), Rick (2), and William(1.5). As you may know, he is an avid fisherman who enjoys exploring new destinations. We are a close knit bunch. While the reality of cancer is frightening and the future uncertain, it is helpful to know that we can make a direct impact on this research for life saving drugs.
We have an amazing opportunity to now travel to Japan to participate in the Moving Mountains for Multiple Myeloma program. In July 2017 we will be climbing Mount Fuji to raise funds and awareness for the Multiple Myeloma Research Foundation (MMRF) Team For Cures. My Dad may someday need these life saving treatments that are a direct result of these funds. To be able to do this climb as a father and daughter team is truly special. This trip is completely paid for by Takeda Oncology, which is also based in Tokyo. We are climbing the 12,389 feet above sea level to show others what myeloma patients are capable of, to support an organization that is the leading funder of myeloma research, and for those patients that are unable to climb because of this disease. While this event will be challenging, it is nothing compared to the challenges faced by patients with multiple myeloma.
In fact, thanks to the important work of the MMRF, the world's leading private funder of myeloma research, the FDA has approved TEN new treatments, including FOUR in just the past 18 months – a track record that's unparalleled in the world of oncology. These drugs have tripled the lifespan of myeloma patients after diagnosis. And now the MMRF is funding over 20 additional treatments in various stages of development, giving hope to tens of thousands of patients and their families.
The MMRF is one of the most highly regarded cancer foundations in the world. An outstanding 90% of the total MMRF budget goes directly towards research and related programming. And the MMRF is in the top 1% of all charities, having earned Charity Navigator’s 4-star rating for the past eleven years in a row.
Please support our participation in the Mount Fuji Trek benefiting the MMRF. We have made a commitment to raise at least $10,000, and we need your help to get there. Please contribute whatever you can. It all adds up!
Please take this opportunity to give back and support this game-changing cancer organization.
Thank you for your support,
Rachel and Jeff
**Want to double your impact? Inquire if your company matches your charitable donations and submit your donation information through your company's portal or HR to receive a match! Forward me your confirmation email and I can get your match added to my fundraising total!